newsfilter
← Latest News
GlobeNewswire·

Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™

Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026Remains well-capitalized and anticipates ending 2026 with significant